SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapiesQuoc Thang Bui, Serge Y. Fuchs, Mayura Dhamdhere et al.|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 0